Sponsor Pipeline

TerSera Therapeutics LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT07310420
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in…		 Trial sites expanded: 15 -> 20 locations
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07310420 A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in… Advanced Breast Cancer Recruiting
Disease Areas
Breast Cancer (1)
Get alerts when TerSera Therapeutics LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free